Editas Medicine, Inc. (EDIT)
2.70
+0.05
(+1.89%)
USD |
NASDAQ |
Sep 11, 16:00
2.70
0.00 (0.00%)
After-Hours: 07:47
Editas Medicine Price to Book Value : 3.937 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 3.937 |
| September 10, 2026 | 3.864 |
| September 09, 2026 | 4.040 |
| September 08, 2026 | 4.419 |
| September 04, 2026 | 4.710 |
| September 03, 2026 | 4.492 |
| September 02, 2026 | 4.492 |
| September 01, 2026 | 4.477 |
| August 31, 2026 | 4.462 |
| August 28, 2026 | 4.608 |
| August 27, 2026 | 4.812 |
| August 26, 2026 | 4.637 |
| August 25, 2026 | 4.783 |
| August 24, 2026 | 4.375 |
| August 21, 2026 | 4.535 |
| August 20, 2026 | 4.287 |
| August 19, 2026 | 4.740 |
| August 18, 2026 | 4.200 |
| August 17, 2026 | 4.142 |
| August 14, 2026 | 4.112 |
| August 13, 2026 | 4.098 |
| August 12, 2026 | 4.142 |
| August 11, 2026 | 4.302 |
| August 10, 2026 | 4.098 |
| August 07, 2026 | 4.200 |
| Date | Value |
|---|---|
| August 06, 2026 | 4.229 |
| August 05, 2026 | 4.010 |
| August 04, 2026 | 4.040 |
| August 03, 2026 | 3.864 |
| July 31, 2026 | 3.762 |
| July 30, 2026 | 3.923 |
| July 29, 2026 | 3.792 |
| July 28, 2026 | 3.821 |
| July 27, 2026 | 3.908 |
| July 24, 2026 | 3.792 |
| July 23, 2026 | 3.981 |
| July 22, 2026 | 4.054 |
| July 21, 2026 | 4.214 |
| July 20, 2026 | 4.200 |
| July 17, 2026 | 4.346 |
| July 16, 2026 | 4.200 |
| July 15, 2026 | 4.433 |
| July 14, 2026 | 4.608 |
| July 13, 2026 | 4.608 |
| July 10, 2026 | 4.754 |
| July 09, 2026 | 4.812 |
| July 08, 2026 | 5.352 |
| July 07, 2026 | 5.469 |
| July 06, 2026 | 5.323 |
| July 02, 2026 | 5.323 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Recursion Pharmaceuticals, Inc. | 1.868 |
| Geron Corp. | 3.967 |
| Halozyme Therapeutics, Inc. | 85.17 |
| Novavax, Inc. | -- |
| AVITA Medical, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 5.809 |
| Price | 2.70 |
| Earnings Yield | -27.58% |
| Market Cap | 414.53M |